Company Filing History:
1 out of 12 
1 out of 1 Years Active: 2017-2023
Title: Daniel Simon Peeper: Innovator in Cancer Treatment
Introduction
Daniel Simon Peeper is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Peeper is recognized for his work in developing novel therapeutic approaches.
Latest Patents
Peeper's latest patents include groundbreaking inventions related to cancer treatment. One of his notable patents is focused on TWEAK-receptor agonists for use in combination with immunotherapy of cancer. This invention involves the use of multivalent ligands that cluster TWEAK-receptors at the cell surface, enhancing the effectiveness of immunotherapy. Additionally, he has developed a patent concerning the combined use of inhibitors of ROCK and proteins of the MAPK/ERK-pathway, specifically targeting KRAS-, NRAS-, or BRAF-mutated cancers, including NRAS mutated melanoma.
Career Highlights
Throughout his career, Daniel Simon Peeper has worked with esteemed institutions such as the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital. His research has focused on innovative cancer therapies, contributing to advancements in the medical field.
Collaborations
Peeper has collaborated with notable professionals in his field, including Thomas Kuilman and David Willem Vredevoogd. These collaborations have further enriched his research and development efforts.
Conclusion
Daniel Simon Peeper is a distinguished inventor whose work in cancer treatment has the potential to transform therapeutic approaches. His innovative patents and collaborations highlight his commitment to advancing medical science.